Literature DB >> 16085381

MRI findings of Wernicke encephalopathy revisited due to hunger strike.

Ercument Unlu1, Bilge Cakir, Talip Asil.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to determine the characteristic magnetic resonance imaging (MRI) findings among a group of patients who presented with Wernicke encephalopathy (WE) due to the neurological complications of a long-term hunger strike (HS).
METHODS: MRI studies also including the fluid-attenuated inversion recovery (FLAIR) sequence and diffusion-weighted imaging (DWI) of six male patients with WE aged from 25 to 38 years (mean age 31 years) were evaluated.
RESULTS: In all subjects, T2-weighted sequences, FLAIR and DWI revealed a signal hyperintensity within the posteromedial thalami and surrounding the third ventricle. In particular, on coronal images, the hyperintense areas around the third ventricle showed a suggestive "double wing" configuration. We observed an increased signal on proton-density and T2-weighted images in the mamillary bodies of three patients. Four patients demonstrated additional hyperintensities within the periaqueductal region and/or the tectal plate. At least one lesion area in five of six patients demonstrated contrast enhancement.
CONCLUSION: The consistent imaging findings of our study suggest that MRI is a reliable means of diagnosing WE. Acute WE is sometimes underdiagnosed, yet early diagnosis and treatment of WE is crucial in order to avoid persistent brain damage. MRI, including postcontrast T1-weighted imaging, DWI beneath standardized T2-weighted imaging, and FLAIR sequences may prove to be a valuable adjunct to clinical diagnosis and to provide additional information in acute and/or subacute WE.

Entities:  

Mesh:

Year:  2005        PMID: 16085381     DOI: 10.1016/j.ejrad.2005.07.002

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  10 in total

1.  Wernicke's encephalopathy in a patient with gastric carcinoma: a diagnosis not to miss.

Authors:  Chandrashekar Udyavara Kudru; Shivashankara Kaniyoor Nagiri; Sandeep Rao
Journal:  BMJ Case Rep       Date:  2014-03-20

2.  Wernicke's encephalopathy in a patient with nephrotic syndrome.

Authors:  Masashi Nishida; Hisashi Sato; Naho Kobayashi; Masafumi Morimoto; Kenji Hamaoka
Journal:  Eur J Pediatr       Date:  2008-09-17       Impact factor: 3.183

3.  Prisoners' competence to die: hunger strike and cognitive competence.

Authors:  Zohar Lederman
Journal:  Theor Med Bioeth       Date:  2018-08

Review 4.  Neuroimaging of rapidly progressive dementias, part 2: prion, inflammatory, neoplastic, and other etiologies.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-14       Impact factor: 3.825

Review 5.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Aissa Haman; Bruce L Miller
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 6.  Neuroimaging of the Wernicke-Korsakoff syndrome.

Authors:  Edith V Sullivan; Adolf Pfefferbaum
Journal:  Alcohol Alcohol       Date:  2008-12-09       Impact factor: 2.826

Review 7.  Neuroimaging of Wernicke's encephalopathy and Korsakoff's syndrome.

Authors:  Young-Chul Jung; Sandra Chanraud; Edith V Sullivan
Journal:  Neuropsychol Rev       Date:  2012-05-11       Impact factor: 7.444

8.  Imaging-based diagnosis of wernicke encephalopathy: a case report.

Authors:  Hosein Delavar Kasmaei; Alireza Baratloo; Maryam Soleymani; Zahra Nasiri
Journal:  Trauma Mon       Date:  2014-09-10

9.  Wernicke's encephalopathy in a patient with masticator and parapharyngeal space abscess: a case report.

Authors:  Young-Jai Chin; Kyu-Ho Yoon; Kwan-Soo Park; Jae-An Park; Min-Ho Woo
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-04-27

Review 10.  MR imaging findings in alcoholic and nonalcoholic acute Wernicke's encephalopathy: a review.

Authors:  Gaetana Manzo; Angela De Gennaro; Attilio Cozzolino; Antonietta Serino; Giacomo Fenza; Andrea Manto
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.